Mirae Asset Global Etfs Holdings »

Catalyst Pharmaceutical Partners shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 66k 19.88
2024-06-30 $962k 64k 15.04

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Global X Fds X Russell 2000 E (RSSL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Cameco Corporation (CCJ)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Intuitive Surgical Com New (ISRG)
Netflix (NFLX)
Trane Technologies SHS (TT)
United Rentals (URI)
Eaton Corp SHS (ETN)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Henderson Group
Royce & Associates
Northern Trust
Kennedy Capital Management
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners